Improving survival of malignant hypertension patients over 40 years

American Journal of Hypertension

Volumn 22, Issue 11, 2009, Pages 1199-1204

  Lane, Deirdre A ^a   Lip, Gregory Y H ^a   Beevers, D Gareth ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADOLESCENT; ADULT; AGED; ARTICLE; DIASTOLIC BLOOD PRESSURE; ETHNIC GROUP; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTENSION; MORTALITY; PRIORITY JOURNAL; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; DEMOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FORECASTING; HUMANS; HYPERTENSION, MALIGNANT; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 70350571640     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.153     Document Type: Article

References (15)

1. Harington M, Kincaid-Smith P, McMichael J. Results of treatment in malignant hypertension: a seven-year experience in 94 cases. Br Med J 1959; 2:969-980.
2. Keith NM, Wagener H P, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939; 196:332-339.
3. Leishman AW. Hypertension: treated and untreated; a study of 400 cases. Br Med J 1959; 1:1361-1363.
4. Lip GY, Beevers M, Beevers G. The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England. J Hypertens 1994; 12:1297-1305.
5. Scarpelli PT, Livi R, Caselli GM, Di Maria L, Teghini L, Montemurro V, Toti G, Becucci A. Accelerated (malignant) hypertension: a study of 121 cases between 1974 and 1996. J Nephrol 1997; 10:207-215.
6. van den Born BJ, Koopmans R P, Groeneveld JO, van Montfrans GA. Ethnic disparities in the incidence, presentation and complications of malignant hypertension. J Hypertens 2006; 24:2299-2304.
7. Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens 1995; 13:915-924.
8. Clough CG, Beevers DG, Beevers M. The survival of malignant hypertension in blacks, whites and Asians in Britain. J Hum Hypertens 1990; 4:94-96.
9. Edmunds E, Beevers DG, Lip GY. What has happened to malignant hypertension? A disease no longer vanishing. J Hum Hypertens 2000; 14:159-161.
10. Pohl JE, Thurston H, Swales JD. Hypertension with renal impairment: influence of intensive therapy. Q J Med 1974; 43:569-581.
11. Sokolow M, Perloff D. Five year survival of consecutive patients with malignant hypertension treated with antihypertensive agents. Am J Cardiol 1960; 6: 858-863.
12. Gudbrandsson T, Hansson L, Herlitz H, Andrèn L. Malignant hypertension-improving prognosis in a rare disease. Acta Med Scand 1979; 206:495-499.
13. Perry HM, Freis ED, Frohlich ED. Department of Veterans Affairs hypertension meeting: a proposal for improved care. Hypertension 2000; 35:853-857. Office for National. Statistics. Census data (2009).
14. Scarpelli PT, Gallo M, De Cesaris F, Chiari G, Dedola G, Cappeli S, Becucci A, Becherelli P, Tosi B, Fanetti C, Fanelli R. Continuing follow-up of malignant hypertension. J Nephrol 2002; 15:431-437.
15. Perry HM, Schroeder HA. The effect of treatment on mortality rates in severe hypertension; a comparison of medical and surgical regimens. AMA Arch Intern Med 1958; 102:418-425.